Neurologic alterations due to respiratory virus infections

Frontiers in Cellular Neuroscience

Volumn 12, Issue , 2018, Pages

  Bohmwald, Karen ^a   Gálvez, Nicolás M S ^a   Ríos, Mariana ^a   Kalergis, Alexis M ^a,b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

CNS pathologies; HCoV; HMPV; HRSV; Influenza virus; Respiratory virus

Indexed keywords

INTERLEUKIN 6;

ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN DISEASE; CEREBROSPINAL FLUID; COGNITION; CORONAVIRIDAE; DIARRHEA; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPTIC STATE; FEBRILE CONVULSION; GUILLAIN BARRE SYNDROME; HEADACHE; HERPESVIRIDAE; HIPPOCAMPUS; HOSPITALIZATION; HUMAN; HUMAN METAPNEUMOVIRUS; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNE RESPONSE; INFLUENZA VIRUS; MEASLES VIRUS; MENTAL DISEASE; MICROGLIA; MORTALITY; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NERVE; PNEUMONIA; RESPIRATORY TRACT INFECTION; RESPIRATORY VIRUS; REVIEW; VIRUS INFECTION; VIRUS REPLICATION;

EID: 85056855752     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2018.00386     Document Type: Review

References (133)

1. Afonso C. L., Amarasinghe G. K., Bányai K., Bào Y., Basler C. F., Bavari S.. (2016). Taxonomy of the order Mononegavirales: update 2016. Arch. Virol. 161, 2351–2360. 10.1007/s00705-016-2880-127216929.
2. Akins P. T., Belko J., Uyeki T. M., Axelrod Y., Lee K. K., Silverthorn J., (2010). H1N1 encephalitis with malignant edema and review of neurologic complications from influenza. Neurocrit. Care 13, 396–406. 10.1007/s12028-010-9436-020811962.
3. Algahtani H., Subahi A., Shirah B., (2016). Neurological complications of middle east respiratory syndrome coronavirus: a report of two cases and review of the literature. Case Rep. Neurol. Med. 2016:3502683. 10.1155/2016/350268327239356.
4. Alvarez R., Harrod K. S., Shieh W.-J., Zaki S., Tripp R. A., (2004). Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies. J. Virol. 78, 14003–14011. 10.1128/jvi.78.24.14003-14011.200415564507.
5. Amarasinghe G. K., Aréchiga Ceballos N. G., Banyard A. C., Basler C. F., Bavari S., Bennett A. J.. (2018). Taxonomy of the order Mononegavirales: update 2018. Arch. Virol. 163, 2283–2294. 10.1007/s00705-018-3814-x29637429.
6. Antonucci R., Chiappe S., Porcella A., Rosatelli D., Fanos V., (2010). Bronchiolitis-associated encephalopathy in critically-ill infants: an underestimated complication? J. Matern. Fetal Neonatal. Med. 23, 431–436. 10.1080/1476705090318418119701864.
7. Antonucci R., Fanos V., (2005). Acute encephalopathy associated with respiratory syncytial virus infections in childhood. A literature review. Minerva Pediatr. 57, 137–142. 16170298.
8. Arbour N., Day R., Newcombe J., Talbot P. J., (2000). Neuroinvasion by human respiratory coronaviruses. J. Virol. 74, 8913–8921. 10.1128/jvi.74.19.8913-8921.200010982334.
9. Arnold J. C., Singh K. K., Milder E., Spector S. A., Sawyer M. H., Gavali S.. (2009). Human metapneumovirus associated with central nervous system infection in children. Pediatr. Infect. Dis. J. 28, 1057–1060. 10.1097/inf.0b013e3181acd22119755929.
10. Asadi-Pooya A. A., Yaghoubi E., Nikseresht A., Moghadami M., Honarvar B., (2011). The neurological manifestations of H1N1 influenza infection; diagnostic challenges and recommendations. Iran. J. Med. Sci. 36, 36–39. 23365476.
11. Barthold S. W., de Souza M. S., Smith A. L., (1990). Susceptibility of laboratory mice to intranasal and contact infection with coronaviruses of other species. Lab. Anim. Sci. 40, 481–485. 2170746.
12. Bergmann C. C., Lane T. E., Stohlman S. A., (2006). Coronavirus infection of the central nervous system: host-virus stand-off. Nat. Rev. Microbiol. 4, 121–132. 10.1038/nrmicro134316415928.
13. Bouvier N. M., Palese P., (2008). The biology of influenza viruses. Vaccine 26, D49–D53. 10.1016/j.vaccine.2008.07.03919230160.
14. Burks J. S., DeVald B. L., Jankovsky L. D., Gerdes J. C., (1980). Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients. Science 209, 933–934. 10.1126/science.74038607403860.
15. Cabeça T. K., Granato C., Bellei N., (2013). Epidemiological and clinical features of human coronavirus infections among different subsets of patients. Influenza Other Respir. Viruses 7, 1040–1047. 10.1111/irv.1210123462106.
16. Cappel R., Thiry L., Clinet G., (1975). Viral antibodies in the CSF after acute CNS infections. Arch. Neurol. 32, 629–631. 10.1001/archneur.1975.004905100850081164214.
17. Cavallaro J. J., Maassab H. F., (1966). Adaptation of respiratory syncytial (RS) virus to brain of suckling mice. Proc. Soc. Exp. Biol. Med. 121, 37–41. 10.3181/00379727-121-306915323239.
18. Cavallaro J. J., Maassab H. F., Abrams G. D., (1967). An immunofluorescent and histopathological study of respiratory syncytial (RS) virus encephalitis in suckling mice. Proc. Soc. Exp. Biol. Med. 124, 1059–1064. 10.3181/00379727-124-319235337605.
19. Chiu S. S., Tse C. Y. C., Lau Y. L., Peiris M., (2001). Influenza a infection is an important cause of febrile seizures. Pediatrics 108:E63. 10.1542/peds.108.4.e6311581471.
20. Dahm T., Rudolph H., Schwerk C., Schroten H., Tenenbaum T., (2016). Neuroinvasion and inflammation in viral central nervous system infections. Mediators Inflamm. 2016:8562805. 10.1155/2016/856280527313404.
21. Desforges M., Le Coupanec A., Brison É., Meessen-Pinard M., Talbot P. J., (2014a). “Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans,” in Infectious Diseases and Nanomedicine I, eds Adhikari R., Thapa S., (India: Springer), 75–96.
22. Desforges M., Le Coupanec A., Stodola J. K., Meessen-Pinard M., Talbot P. J., (2014b). Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis. Virus Res. 194, 145–158. 10.1016/j.virusres.2014.09.01125281913.
23. Ding Y. Q., He L., Zhang Q. L., Huang Z. X., Che X. Y., Hou J. L.. (2004). Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J. Pathol. 203, 622–630. 10.1002/path.156015141376.
24. Edwards K. M., Zhu Y., Griffin M. R., Weinberg G. A., Hall C. B., Szilagyi P. G.. (2013). Burden of human metapneumovirus infection in young children. N. Engl. J. Med. 368, 633–643. 10.1056/NEJMoa120463023406028.
25. Eisenhut M., (2006). Extrapulmonary manifestations of severe respiratory syncytial virus infection—a systematic review. Crit. Care 10:R107. 10.1186/cc498416859512.
26. Englund J., Feuchtinger T., Ljungman P., (2011). Viral infections in immunocompromised patients. Biol. Blood Marrow Transplant. 17, S2–S5. 10.1016/j.bbmt.2010.11.00821195305.
27. Espinoza J. A., Bohmwald K., Céspedes P. F., Gómez R. S., Riquelme S. A., Cortés C. M.. (2013). Impaired learning resulting from respiratory syncytial virus infection. Proc. Natl. Acad. Sci. U S A 110, 9112–9117. 10.1073/pnas.121750811023650398.
28. Esposito S., Salice P., Bosis S., Ghiglia S., Tremolati E., Tagliabue C.. (2010). Altered cardiac rhythm in infants with bronchiolitis and respiratory syncytial virus infection. BMC Infect. Dis. 10, 305–305. 10.1186/1471-2334-10-30520969802.
29. Fok A., Mateevici C., Lin B., Chandra R. V., Chong V. H. T., (2015). Encephalitis-associated human metapneumovirus pneumonia in adult, australia. Emerg. Infect. Dis. 21, 2074–2076. 10.3201/eid2111.15060826488420.
30. Gaunt E. R., Hardie A., Claas E. C. J., Simmonds P., Templeton K. E., (2010). Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J. Clin. Microbiol. 48, 2940–2947. 10.1128/jcm.00636-1020554810.
31. Glass W. G., Subbarao K., Murphy B., Murphy P. M., (2004). Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J. Immunol. 173, 4030–4039. 10.4049/jimmunol.173.6.403015356152.
32. Goenka A., Michael B. D., Ledger E., Hart I. J., Absoud M., Chow G.. (2014). Neurological manifestations of influenza infection in children and adults: results of a national british surveillance study. Clin. Infect. Dis. 58, 775–784. 10.1093/cid/cit92224352349.
33. Gonzalez-Scarano F., Tyler K. L., (1987). Molecular pathogenesis of neurotropic viral infections. Ann. Neurol. 22, 565–574. 10.1002/ana.4102205023322182.
34. Gorbalenya A. E., Enjuanes L., Ziebuhr J., Snijder E. J., (2006). Nidovirales: evolving the largest RNA virus genome. Virus Res. 117, 17–37. 10.1016/j.virusres.2006.01.01716503362.
35. Hamelin M. E., Prince G. A., Gomez A. M., Kinkead R., Boivin G., (2006). Human metapneumovirus infection induces long-term pulmonary inflammation associated with airway obstruction and hyperresponsiveness in mice. J. Infect. Dis. 193, 1634–1642. 10.1086/50426216703506.
36. Hanna S., Tibby S., Durward A., Murdoch I., (2003). Incidence of hyponatraemia and hyponatraemic seizures in severe respiratory syncytial virus bronchiolitis. Acta Paediatr. 92, 430–434. 10.1111/j.1651-2227.2003.tb00573.x12801108.
37. Hata M., Ito M., Kiyosawa S., Kimpara Y., Tanaka S., Yamashita T.. (2007). A fatal case of encephalopathy possibly associated with human Metapneumovirus infection. Jpn. J. Infect. Dis. 60, 328–329. 17881883.
38. Hirayama K., Sakazaki H., Murakami S., Yonezawa S., Fujimoto K., Seto T.. (1999). Sequential MRI, SPECT and PET in respiratory syncytial virus encephalitis. Pediatr. Radiol. 29, 282–286. 10.1007/s00247005058910199908.
39. Hosseini S., Wilk E., Michaelsen-Preusse K., Gerhauser I., Baumgärtner W., Geffers R.. (2018). Long-term neuroinflammation induced by influenza A virus infection and the impact on hippocampal neuron morphology and function. J. Neurosci. 38, 3060–3080. 10.1523/JNEUROSCI.1740-17.201829487124.
40. Hung E. C. W., Chim S. S. C., Chan P. K. S., Tong Y. K., Ng E. K. O., Chiu R. W. K.. (2003). Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin. Chem. 49, 2108–2109. 10.1373/clinchem.2003.02543714633896.
41. Jacomy H., Fragoso G., Almazan G., Mushynski W. E., Talbot P. J., (2006). Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice. Virology 349, 335–346. 10.1016/j.virol.2006.01.04916527322.
42. Jacomy H., Talbot P. J., (2003). Vacuolating encephalitis in mice infected by human coronavirus OC43. Virology 315, 20–33. 10.1016/s0042-6822(03)00323-414592756.
43. Jang H., Boltz D., McClaren J., Pani A. K., Smeyne M., Korff A.. (2012). Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice. J. Neurosci. 32, 1545–1559. 10.1523/JNEUROSCI.5123-11.201222302798.
44. Jang H., Boltz D., Sturm-Ramirez K., Shepherd K. R., Jiao Y., Webster R.. (2009). Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc. Natl. Acad. Sci. U S A 106, 14063–14068. 10.1073/pnas.090009610619667183.
45. Jeannet N., van den Hoogen B. G., Schefold J. C., Suter-Riniker F., Sommerstein R., (2017). Cerebrospinal fluid findings in an adult with human metapneumovirus-associated encephalitis. Emerg. Infect. Dis. 23, 370–370. 10.3201/eid2302.16133728098534.
46. Jurgens H. A., Amancherla K., Johnson R. W., (2012). Influenza infection induces neuroinflammation, alters hippocampal neuron morphology, and impairs cognition in adult mice. J. Neurosci. 32, 3958–3968. 10.1523/JNEUROSCI.6389-11.201222442063.
47. Kaida A., Iritani N., Kubo H., Shiomi M., Kohdera U., Murakami T., (2006). Seasonal distribution and phylogenetic analysis of human metapneumovirus among children in Osaka City, Japan. J. Clin. Virol. 35, 394–399. 10.1016/j.jcv.2005.12.00916460998.
48. Kapila C. C., Kaul S., Kapur S. C., Kalayanam T. S., Banerjee D., (1958). Neurological and hepatic disorders associated with influenza. Br. Med. J. 2, 1311–1314. 10.1136/bmj.2.5108.131113596594.
49. Kawashima H., Ioi H., Ushio M., Yamanaka G., Matsumoto S., Nakayama T., (2009). Cerebrospinal fluid analysis in children with seizures from respiratory syncytial virus infection. Scand. J. Infect. Dis. 41, 228–231. 10.1080/0036554080266954319117245.
50. Kawashima H., Kashiwagi Y., Ioi H., Morichi S., Oana S., Yamanaka G.. (2012). Production of chemokines in respiratory syncytial virus infection with central nervous system manifestations. J. Infect. Chemother. 18, 827–831. 10.1007/s10156-012-0418-322572852.
51. Kho N., Kerrigan J. F., Tong T., Browne R., Knilans J., (2004). Respiratory syncytial virus infection and neurologic abnormalities: retrospective cohort study. J. Child Neurol. 19, 859–864. 10.1177/0883073804019011030115658790.
52. King A. M. Q., Adams M. J., Carstens E. B., Lefkowitz E. J., (Eds). (2012). “Classification and nomenclature of viruses,” in Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses (San Diego: Elsevier), 1326–1327.
53. King A. M. Q., Lefkowitz E. J., Mushegian A. R., Adams M. J., Dutilh B. E., Gorbalenya A. E.. (2018). Changes to taxonomy and the international code of virus classification and nomenclature ratified by the international committee on taxonomy of viruses (2018). Arch. Virol. 163, 2601–2631. 10.1007/s00705-018-3847-129754305.
54. Kirin B. K., Topić R. Z., Dodig S., (2013). Hepatitis during respiratory syncytial virus infection—a case report. Biochem. Med. 23, 112–116. 10.11613/bm.2013.01423457772.
55. Koyuncu O. O., Hogue I. B., Enquist L. W., (2013). Virus infections in the nervous system. Cell Host Microbe 13, 379–393. 10.1016/j.chom.2013.03.01023601101.
56. Kutter J. S., Spronken M. I., Fraaij P. L., Fouchier R. A. M., Herfst S., (2018). Transmission routes of respiratory viruses among humans. Curr. Opin. Virol. 28, 142–151. 10.1016/j.coviro.2018.01.00129452994.
57. Landau Y. E., Grisaru-Soen G., Reif S., Fattal-Valevski A., (2011). Pediatric neurologic complications associated with influenza A H1N1. Pediatr. Neurol. 44, 47–51. 10.1016/j.pediatrneurol.2010.08.01121147387.
58. Lau K.-K., Yu W.-C., Chu C.-M., Lau S.-T., Sheng B., Yuen K. Y., (2004). Possible central nervous system infection by SARS coronavirus. Emerg. Infect. Dis. 10, 342–344. 10.3201/eid1002.03063815030709.
59. Li X.-Q., Fu Z. F., Alvarez R., Henderson C., Tripp R. A., (2006). Respiratory syncytial virus (RSV) infects neuronal cells and processes that innervate the lung by a process involving RSV G protein. J. Virol. 80, 537–540. 10.1128/jvi.80.1.537-540.200616352577.
60. Li Y., Fu L., Gonzales D. M., Lavi E., (2004). Coronavirus neurovirulence correlates with the ability of the virus to induce proinflammatory cytokine signals from astrocytes and microglia. J. Virol. 78, 3398–3406. 10.1128/jvi.78.7.3398-3406.200415016862.
61. Li Y., Li H., Fan R., Wen B., Zhang J., Cao X.. (2016). Coronavirus infections in the central nervous system and respiratory tract show distinct features in hospitalized children. Intervirology 59, 163–169. 10.1159/00045306628103598.
62. Li F., Wang Y., Yu L., Cao S., Wang K., Yuan J.. (2015). Viral infection of the central nervous system and neuroinflammation precede blood-brain barrier disruption during japanese encephalitis virus infection. J. Virol. 89, 5602–5614. 10.1128/jvi.00143-1525762733.
63. Liang C.-Y., Yang C.-H., Lin J.-N., (2018). Focal encephalitis, meningitis, and acute respiratory distress syndrome associated with influenza A infection. Med. Princ. Pract. 27, 193–196. 10.1159/00048739829402867.
64. Liu Y. R., Haas D. L., Poore S., Isakovic S., Gahan M., Mahalingam S.. (2009). Human metapneumovirus establishes persistent infection in the lungs of mice and is reactivated by glucocorticoid treatment. J. Virol. 83, 6837–6848. 10.1128/jvi.00379-0919357175.
65. Louten J., (2016). “Chapter 10—influenza viruses,” in Essential Human Virology, ed. Louten J., (Boston: Academic Press), 171–191.
66. Manjunatha N., Math S., Kulkarni G., Chaturvedi S., (2011). The neuropsychiatric aspects of influenza/swine flu: a selective review. Ind. Psychiatry J. 20, 83–90. 10.4103/0972-6748.10247923271861.
67. Matoba Y., Aoki Y., Tanaka S., Yahagi K., Shimotai Y., Matsuzaki Y.. (2015). An outbreak of human coronavirus OC43 during the 2014–2015 influenza season in yamagata, Japan. Jpn. J. Infect. Dis. 68, 442–445. 10.7883/yoken.JJID.2015.29226399927.
68. Matsuda K., Park C. H., Sunden Y., Kimura T., Ochiai K., Kida H.. (2004). The vagus nerve is one route of transneural invasion for intranasally inoculated influenza A virus in mice. Vet. Pathol. 41, 101–107. 10.1354/vp.41-2-10115017022.
69. Matsuda K., Shibata T., Sakoda Y., Kida H., Kimura T., Ochiai K.. (2005). In vitro demonstration of neural transmission of avian influenza A virus. J. Gen. Virol. 86, 1131–1139. 10.1099/vir.0.80704-015784907.
70. McGavern D. B., Kang S. S., (2011). Illuminating viral infections in the nervous system. Nat. Rev. Immunol. 11, 318–329. 10.1038/nri297121508982.
71. Meijer W. J., Linn F. H. H., Wensing A. M. J., Leavis H. L., van Riel D., GeurtsvanKessel C. H.. (2016). Acute influenza virus-associated encephalitis and encephalopathy in adults: a challenging diagnosis. JMM Case Rep. 3:e005076. 10.1099/jmmcr.0.00507628348797.
72. Miner J. J., Diamond M. S., (2016). Mechanisms of restriction of viral neuroinvasion at the blood-brain barrier. Curr. Opin. Immunol. 38, 18–23. 10.1016/j.coi.2015.10.00826590675.
73. Miyamoto K., Fujisawa M., Hozumi H., Tsuboi T., Kuwashima S., Hirao J.-I.. (2013). Systemic inflammatory response syndrome and prolonged hypoperfusion lesions in an infant with respiratory syncytial virus encephalopathy. J. Infect. Chemother. 19, 978–982. 10.1007/s10156-013-0558-023354937.
74. Mizuguchi M., (2013). Influenza encephalopathy and related neuropsychiatric syndromes. Influenza Other Respir. Viruses 7, 67–71. 10.1111/irv.1217724215384.
75. Mizuguchi M., Yamanouchi H., Ichiyama T., Shiomi M., (2007). Acute encephalopathy associated with influenza and other viral infections. Acta Neurol. Scand. 115, 45–56. 10.1111/j.1600-0404.2007.00809.x17362276.
76. Morichi S., Kawashima H., Ioi H., Ushio M., Yamanaka G., Kashiwagi Y.. (2009). Cerebrospinal fluid NOx (nitrite/nitrate) in RSV-infected children with CNS symptoms. J. Infect. 59, 299–301. 10.1016/j.jinf.2009.07.00819665802.
77. Morichi S., Kawashima H., Ioi H., Yamanaka G., Kashiwagi Y., Hoshika A.. (2011). Classification of acute encephalopathy in respiratory syncytial virus infection. J. Infect. Chemother. 17, 776–781. 10.1007/s10156-011-0259-521647570.
78. Morichi S., Morishita N., Ishida Y., Oana S., Yamanaka G., Kashiwagi Y.. (2017). Examination of neurological prognostic markers in patients with respiratory syncytial virus-associated encephalopathy. Int. J. Neurosci. 127, 44–50. 10.3109/00207454.2016.113895126732732.
79. Morton R. E., Dinwiddie R., Marshall W. C., Matthew D. J., (1981). Respiratory syncytial virus infection causing neurological disorder in neonates. Lancet 317, 1426–1427. 10.1016/s0140-6736(81)92609-x6113386.
80. Muhammad Ismail H. I., Teh C. M., Lee Y. L., (2015). Neurologic manifestations and complications of pandemic influenza A H1N1 in Malaysian children: what have we learnt from the ordeal? Brain Dev. 37, 120–129. 10.1016/j.braindev.2014.03.00824746706.
81. Murray R. S., Brown B., Brain D., Cabirac G. F., (1992). Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann. Neurol. 31, 525–533. 10.1002/ana.4103105111596089.
82. Newland J. G., Romero J. R., Varman M., Drake C., Holst A., Safranek T.. (2003). Encephalitis associated with influenza B virus infection in 2 children and a review of the literature. Clin. Infect. Dis. 36, e87–e95. 10.1086/36818412652406.
83. Ng Y. T., Cox C., Atkins J., Butler I. J., (2001). Encephalopathy associated with respiratory syncytial virus bronchiolitis. J. Child Neurol. 16, 105–108. 10.2310/7010.2001.691311292214.
84. Nichols W. G., Peck Campbell A. J., Boeckh M., (2008). Respiratory viruses other than influenza virus: impact and therapeutic advances. Clin. Microbiol. Rev. 21, 274–290. 10.1128/cmr.00045-0718400797.
85. Niizuma T., Okumura A., Kinoshita K., Shimizu T., (2014). Acute encephalopathy associated with human metapneumovirus infection. Jpn. J. Infect. Dis. 67, 213–215. 10.7883/yoken.67.21324858612.
86. Otake Y., Yamagata T., Morimoto Y., Imi M., Mori M., Aihara T.. (2007). Elevated CSF IL-6 in a patient with respiratory syncytial virus encephalopathy. Brain Dev. 29, 117–120. 10.1016/j.braindev.2006.06.00816920309.
87. Paisley J. W., Bruhn F. W., Lauer B. A., McIntosh K., (1978). Type a2 influenza viral infections in children. Am. J. Dis. Child. 132, 34–36. 10.1001/archpedi.1978.02120260036007623060.
88. Paiva T. M., Theotonio G., Paulino R. S., Benega M. A., Silva D. B. B., Borborema S. E. T.. (2013). Influenza virus A(H3N2) strain isolated from cerebrospinal fluid from a patient presenting myelopathy post infectious. J. Clin. Virol. 58, 283–285. 10.1016/j.jcv.2013.05.02123809474.
89. Paksu M. S., Aslan K., Kendirli T., Akyildiz B. N., Yener N., Yildizdas R. D.. (2018). Neuroinfluenza: evaluation of seasonal influenza associated severe neurological complications in children (a multicenter study). Childs Nerv. Syst. 34, 335–347. 10.1007/s00381-017-3554-328762041.
90. Park C. H., Ishinaka M., Takada A., Kida H., Kimura T., Ochiai K.. (2002). The invasion routes of neurovirulent A Hong Kong 483/97 (H5N1) influenza virus into the central nervous system after respiratory infection in mice. Arch. Virol. 147, 1425–1436. 10.1007/s00705-001-0750-x12111416.
91. Peiris J. S., Tang W. H., Chan K. H., Khong P. L., Guan Y., Lau Y. L.. (2003). Children with respiratory disease associated with metapneumovirus in Hong Kong. Emerg. Infect. Dis. 9, 628–633. 10.3201/eid0906.03000912781000.
92. Perlman S., Evans G., Afifi A., (1990). Effect of olfactory-bulb ablation on spread of a neurotropic coronavirus into the mouse-brain. J. Exp. Med. 172, 1127–1132. 10.1084/jem.172.4.11271698910.
93. Popescu C. P., Florescu S. A., Lupulescu E., Zaharia M., Tardei G., Lazar M.. (2017). Neurologic complications of influenza B virus infection in adults, Romania. Emerg. Infect. Dis. 23, 574–581. 10.3201/eid2304.16131728322689.
94. Resa-Infante P., Recuero-Checa M. Á., Zamarreño N., Llorca Ó., Ortín J., (2010). Structural and functional characterization of an influenza virus RNA polymerase-genomic RNA complex. J. Virol. 84, 10477–10487. 10.1128/jvi.01115-1020702645.
95. Roe K., Kumar M., Lum S., Orillo B., Nerurkar V. R., Verma S., (2012). West Nile virus-induced disruption of the blood-brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases. J. Gen. Virol. 93, 1193–1203. 10.1099/vir.0.040899-022398316.
96. Ruisanchez-Nieva A., Martinez-Arroyo A., Gomez-Beldarrain M., Bocos Portillo J., Garcia-Monco J. C., (2017). Influenza-associated seizures in healthy adults: report of 3 cases. Epilepsy Behav. Case Rep. 8, 12–13. 10.1016/j.ebcr.2017.01.00328652973.
97. Sadasivan S., Zanin M., O’Brien K., Schultz-Cherry S., Smeyne R. J., (2015). Induction of microglia activation after infection with the non-neurotropic A/CA/04/2009 H1N1 influenza virus. PLoS One 10:e0124047. 10.1371/journal.pone.012404725861024.
98. Salonen O., Koskiniemi M., Saari A., Myllylä V., Pyhälä R., Airaksinen L.. (1997). Myelitis associated with influenza A virus infection. J. Neurovirol. 3, 83–85. 10.3109/135502897090157979147826.
99. Sánchez Fernández I., Rebollo Polo M., Muñoz-Almagro C., Monfort Carretero L., Fernández Ureña S., Rueda Muñoz A.. (2012). Human metapneumovirus in the cerebrospinal fluid of a patient with acute encephalitis. Arch. Neurol. 69, 649–652. 10.1001/archneurol.2011.109422232205.
100. Schildgen O., Glatzel T., Geikowski T., Scheibner B., Matz B., Bindl L.. (2005). Human metapneumovirus RNA in encephalitis patient. Emerg. Infect. Dis. 11, 467–470. 10.3201/eid1103.04067615757568.
101. Schildgen V., van den Hoogen B., Fouchier R., Tripp R. A., Alvarez R., Manoha C.. (2011). Human metapneumovirus: lessons learned over the first decade. Clin. Microbiol. Rev. 24, 734–754. 10.1128/cmr.00015-1121976607.
102. Shinya K., Shimada A., Ito T., Otsuki K., Morita T., Tanaka H.. (2000). Avian influenza virus intranasally inoculated infects the central nervous system of mice through the general visceral afferent nerve. Arch. Virol. 145, 187–195. 10.1007/s00705005001610664417.
103. Shinya K., Silvano F. D., Morita T., Shimada A., Nakajima M., Ito T.. (1998). Encephalitis in mice inoculated intranasally with an influenza virus strain originated from a water bird. J. Vet. Med. Sci. 60, 627–629. 10.1292/jvms.60.6279637299.
104. Simon M., Hernu R., Cour M., Casalegno J. S., Lina B., Argaud L., (2013). Fatal influenza A(H1N1)pdm09 encephalopathy in immunocompetent man. Emerg. Infect. Dis. 19, 1005–1007. 10.3201/eid1906.13006223735733.
105. Sivadon-Tardy V., Orlikowski D., Porcher R., Sharshar T., Durand M.-C., Enouf V.. (2009). Guillain-barré syndrome and influenza virus infection. Clin. Infect. Dis. 48, 48–56. 10.1086/59412419025491.
106. Skowronski D. M., Chambers C., De Serres G., Dickinson J. A., Winter A.-L., Hickman R.. (2018). Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018. Eurosurveillance 23:5. 10.2807/1560-7917.es.2018.23.5.18-0003529409570.
107. Steininger C., Popow-Kraupp T., Laferl H., Seiser A., Gödl I., Djamshidian S.. (2003). Acute encephalopathy associated with influenza A virus infection. Clin. Infect. Dis. 36, 567–574. 10.1086/36762312594636.
108. Stewart J. N., Mounir S., Talbot P. J., (1992). Human coronavirus gene-expression in the brains of multiple-sclerosis patients. Virology 191, 502–505. 10.1016/0042-6822(92)90220-j1413524.
109. St-Jean J. R., Desforges M., Almazán F., Jacomy H., Enjuanes L., Talbot P. J., (2006). Recovery of a neurovirulent human coronavirus OC43 from an infectious cDNA clone. J. Virol. 80, 3670–3674. 10.1128/jvi.80.7.3670-3674.200616537637.
110. St-Jean J. R., Jacomy H., Desforges M., Vabret A., Freymuth F., Talbot P. J., (2004). Human respiratory coronavirus oc43: genetic stability and neuroinvasion. J. Virol. 78, 8824–8834. 10.1128/jvi.78.16.8824-8834.200415280490.
111. Su S., Fu X., Li G., Kerlin F., Veit M., (2017). Novel influenza D virus: epidemiology, pathology, evolution and biological characteristics. Virulence 8, 1580–1591. 10.1080/21505594.2017.136521628812422.
112. Suen W. W., Prow N. A., Hall R. A., Bielefeldt-Ohmann H., (2014). Mechanism of west nile virus neuroinvasion: a critical appraisal. Viruses 6, 2796–2825. 10.3390/v607279625046180.
113. Swanson P. A., II. McGavern D. B., (2015a). “Chapter 2. Portals of viral entry into the central nervous system,” in The Blood-Brain Barrier in Health and Disease, ed. Dorovini-Zis K., (Boca Raton, FL: CRC Press), 23–47.
114. Swanson P. A., II. McGavern D. B., (2015b). Viral diseases of the central nervous system. Curr. Opin. Virol. 11, 44–54. 10.1016/j.coviro.2014.12.00925681709.
115. Sweetman L. L., Ng Y. T., Butler I. J., Bodensteiner J. B., (2005). Neurologic complications associated with respiratory syncytial virus. Pediatr. Neurol. 32, 307–310. 10.1016/j.pediatrneurol.2005.01.01015866430.
116. Talbot H. K., Falsey A. R., (2010). The diagnosis of viral respiratory disease in older adults. Clin. Infect. Dis. 50, 747–751. 10.1086/65048620121411.
117. Tan Y. L., Wee T. C., (2017). Adult human metapneumovirus encephalitis: a case report highlighting challenges in clinical management and functional outcome. Med. J. Malaysia 72, 372–373. 29308778.
118. Tregoning J. S., Schwarze J., (2010). Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin. Microbiol. Rev. 23, 74–98. 10.1128/cmr.00032-0920065326.
119. Turner E. B., (1919). Discussion on influenza. Proc. R. Soc. Med. 12, 76–90. 19980438.
120. van den Hoogen B. G., Bestebroer T. M., Osterhaus A. D. M. E., Fouchier R. A. M., (2002). Analysis of the genomic sequence of a human metapneumovirus. Virology 295, 119–132. 10.1006/viro.2001.135512033771.
121. van den Hoogen B. G., de Jong J., Groen J., Kuiken T., de Groot R., Fouchier R. A. M.. (2001). A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 7, 719–724. 10.1038/8909811385510.
122. Vehapoglu A., Turel O., Uygur Sahin T., Kutlu N. O., Iscan A., (2015). Clinical significance of human metapneumovirus in refractory status epilepticus and encephalitis: case report and review of the literature. Case Rep. Neurol. Med. 2015:131780. 10.1155/2015/13178026664779.
123. Wallace S. J., Zealley H., (1970). Neurological, electroencephalographic, and virological findings in febrile children. Arch. Dis. Child. 45, 611–623. 10.1136/adc.45.243.6114320122.
124. Webster D. L., Gardner A. H., Dye T. J., Chima R. S., (2014). Status epilepticus: a possible association with human metapneumovirus infection. Pediatrics 133, e747–e750. 10.1542/peds.2013-092924515507.
125. Wheeler D. L., Sariol A., Meyerholz D. K., Perlman S., (2018). Microglia are required for protection against lethal coronavirus encephalitis in mice. J. Clin. Invest. 128, 931–943. 10.1172/jci9722929376888.
126. Williams R. K., Jiang G. S., Snyder S. W., Frana M. F., Holmes K. V., (1990). Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis-virus (MHV)-A59 from mouse-liver and identification of a nonfunctional, homologous protein in MHV-resistant SJL/J mice. J. Virol. 64, 3817–3823. 2164599.
127. Xia J.-B., Zhu J., Hu J., Wang L.-M., Zhang H., (2014). H7N9 influenza A-induced pneumonia associated with acute myelitis in an adult. Intern. Med. 53, 1093–1095. 10.2169/internalmedicine.53.180124827492.
128. Xu J., Zhong S., Liu J., Li L., Li Y., Wu X.. (2005). Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin. Infect. Dis. 41, 1089–1096. 10.1086/44446116163626.
129. Xu L., Gao H., Zeng J., Liu J., Lu C., Guan X.. (2018). A fatal case associated with respiratory syncytial virus infection in a young child. BMC Infect. Dis. 18:217. 10.1093/pch/4.7.47429751747.
130. Yeh E. A., Collins A., Cohen M. E., Duffner P. K., Faden H., (2004). Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics 113, e73–e76. 10.1542/peds.113.1.e7314702500.
131. Yu J. E., Kim M., Lee J.-H., Chang B.-J., Song C.-S., Nahm S.-S., (2014). Neonatal influenza infection causes pathological changes in the mouse brain. Vet. Res. 45:63. 10.1186/1297-9716-45-6324917271.
132. Yuan X., Hu T., He H., Qiu H., Wu X., Chen J.. (2018). Respiratory syncytial virus prolifically infects N2a neuronal cells, leading to TLR4 and nucleolin protein modulations and RSV F protein co-localization with TLR4 and nucleolin. J. Biomed. Sci. 25:13. 10.1186/s12929-018-0416-629427996.
133. Zlateva K. T., Van Ranst M., (2004). Detection of subgroup B respiratory syncytial virus in the cerebrospinal fluid of a patient with respiratory syncytial virus pneumonia. Pediatr. Infect. Dis. J. 23, 1065–1066. 10.1097/01.inf.0000143654.12493.c915545869.